Resources
Reaching European attendees, our 2023 Post-ESMO report sought to understand the event’s areas of greatest interest. 95 European oncologists and haematologist-oncologists shared with us the findings and developments they found most exciting.
Learn what respondents thought of the latest advancements including NSCLC, breast cancer, and Urothelial cancer treatments.
Download the report today.
Prescriber Perceptions around CRISPR in 2023 Four years ago, InCrowd assessed the awareness among physicians of nucleic acid-based therapies, their mechanisms of action, and their current and future promise.In considering the 2019 research, InCrowd wanted to...
Prescriber Perspectives on Weight Loss Drugs in 2023 Examine how healthcare professionals (HCPs) view and prescribe weight loss drugs currently on the market in our new Instant Insights report. Fielded in a single day, this report includes responses from 100 qualified...
Physician Perspectives on the 2023 ASCO Annual Meeting Curious what doctors thought about ASCO? Nearly 100 oncologists and hematologist oncologists shared with us the findings and developments they were most excited about. Check-out our 2023 Post-ASCO report to...